Literature DB >> 34726709

Association of Maternal Antidepressant Prescription During Pregnancy With Standardized Test Scores of Danish School-aged Children.

Jakob Christensen1,2, Betina B Trabjerg1,3, Yuelian Sun1,2, Julie Werenberg Dreier1,3.   

Abstract

Importance: Concerns exist about long-term neurodevelopmental consequences of prenatal exposure to antidepressants. Objective: To evaluate whether maternal prescription fill for antidepressants in pregnancy was associated with performance in standardized tests among Danish schoolchildren. Design, Setting, and Participants: Population-based retrospective cohort study of children born in Denmark between January 1, 1997, and December 31, 2009, attending public primary and lower secondary school. The children included had completed a language or mathematics test as part of the Danish National Test Program between January 1, 2010, and December 31, 2018. The age range of the eligible schoolchildren was 7 to 17 years. Exposures: Maternal prescription fill for antidepressants during pregnancy, obtained from the Danish Prescription Register. Main Outcomes and Measures: The difference in standardized scores between children with and without maternal prescription fill for antidepressants in mathematics and language tests (scale, 1-100; higher scores indicate better test results) was estimated using linear regression models, adjusted for relevant confounders. Ten sensitivity analyses were performed, including a sibling-controlled analysis.
Results: Among the 575 369 children included (51.1% males), 10 198 (1.8%) were born to mothers filling an antidepressant prescription during pregnancy. The mean (SD) age of children at the time of testing spanned from 8.9 (0.4) years in grade 2 to 14.9 (0.4) years in grade 8. Maternal prescription fill for antidepressants was significantly associated with a poorer performance in mathematics (mean test scores for the group exposed to maternal antidepressant fill: 52.1 [95% CI, 51.7-52.6] and for the group not exposed to maternal antidepressant fill: 57.4 [95% CI, 57.3-57.4]; adjusted difference, -2.2 [95% CI, -2.7 to -1.6]), but not in language (mean test scores for the exposed group: 53.4 [95% CI, 53.1-53.7] and for the not exposed group: 56.6 [95% CI, 56.5-56.6]; adjusted difference, -0.1 [95% CI, -0.6 to 0.3]). In the sibling-controlled analysis, the adjusted difference in mathematics (mean scores for the exposed group: 53.5 [95% CI, 52.7-54.3] and for the not exposed group: 59.0 [95% CI, 58.9-59.1]) was -2.8 (95% CI, -4.5 to -1.2) and in language (mean test scores for the exposed group: 53.9 [95% CI, 53.2-54.6] and for the not exposed group: 56.6 [95% CI, 56.5-56.7]) was -0.3 (95% CI, -1.9 to 1.2). Conclusions and Relevance: In this study of public schoolchildren in Denmark, children whose mothers had filled prescriptions for antidepressants during pregnancy, compared with children whose mothers did not fill prescriptions for antidepressants during pregnancy, had a 2-point lower standardized test score in mathematics, a difference that was statistically significant, but had no significant difference in language test scores. The magnitude of the difference in the mathematics test score was small and of uncertain clinical importance, and the findings must be weighed against the benefits of treating maternal depression during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34726709      PMCID: PMC8564575          DOI: 10.1001/jama.2021.17380

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  28 in total

1.  Do pregnant women report use of dispensed medications?

Authors:  C Olesen; C Søndergaard; N Thrane; G L Nielsen; L de Jong-van den Berg; J Olsen
Journal:  Epidemiology       Date:  2001-09       Impact factor: 4.822

Review 2.  Review of inverse probability weighting for dealing with missing data.

Authors:  Shaun R Seaman; Ian R White
Journal:  Stat Methods Med Res       Date:  2011-01-10       Impact factor: 3.021

3.  Danish Education Registers.

Authors:  Vibeke M Jensen; Astrid W Rasmussen
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

Review 4.  Serotonin as a developmental signal.

Authors:  P M Whitaker-Azmitia; M Druse; P Walker; J M Lauder
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

5.  Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study.

Authors:  Angela Lupattelli; Olav Spigset; Ingunn Björnsdóttir; Katri Hämeen-Anttila; Ann-Charlotte Mårdby; Alice Panchaud; Romana Gjergja Juraski; Gorazd Rudolf; Marina Odalovic; Mariola Drozd; Michael J Twigg; Herbert Juch; Myla E Moretti; Debra Kennedy; Andre Rieutord; Ksenia Zagorodnikova; Anneke Passier; Hedvig Nordeng
Journal:  Depress Anxiety       Date:  2015-02-20       Impact factor: 6.505

6.  Data Resource Profile: The Danish National Prescription Registry.

Authors:  Anton Pottegård; Sigrun Alba Johannesdottir Schmidt; Helle Wallach-Kildemoes; Henrik Toft Sørensen; Jesper Hallas; Morten Schmidt
Journal:  Int J Epidemiol       Date:  2017-06-01       Impact factor: 7.196

7.  Antidepressant use in pregnancy and the risk of cardiac defects.

Authors:  Krista F Huybrechts; Kristin Palmsten; Jerry Avorn; Lee S Cohen; Lewis B Holmes; Jessica M Franklin; Helen Mogun; Raisa Levin; Mary Kowal; Soko Setoguchi; Sonia Hernández-Díaz
Journal:  N Engl J Med       Date:  2014-06-19       Impact factor: 91.245

8.  Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.

Authors:  Alan S Brown; David Gyllenberg; Heli Malm; Ian W McKeague; Susanna Hinkka-Yli-Salomäki; Miia Artama; Mika Gissler; Keely Cheslack-Postava; Myrna M Weissman; Jay A Gingrich; Andre Sourander
Journal:  JAMA Psychiatry       Date:  2016-11-01       Impact factor: 21.596

9.  Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: A Systematic Review.

Authors:  Anna-Sophie Rommel; Veerle Bergink; Xiaoqin Liu; Trine Munk-Olsen; Nina Maren Molenaar
Journal:  J Clin Psychiatry       Date:  2020-05-12       Impact factor: 4.384

10.  Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.

Authors:  Helga Zoega; Helle Kieler; Mette Nørgaard; Kari Furu; Unnur Valdimarsdottir; Lena Brandt; Bengt Haglund
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

View more
  4 in total

Review 1.  Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child.

Authors:  Lindsay G Lebin; Andrew M Novick
Journal:  Curr Psychiatry Rep       Date:  2022-10-01       Impact factor: 8.081

2.  Analysis of Prenatal Exposure to Opioid Analgesics and Scholastic Skills in Children in Fifth Grade in Norway.

Authors:  Johanne Naper Trønnes; Angela Lupattelli; Eivind Ystrom; Hedvig Nordeng
Journal:  JAMA Netw Open       Date:  2022-07-01

3.  Antidepressant use during pregnancy and risk of adverse neonatal outcomes: A comprehensive investigation of previously identified associations.

Authors:  Anna-Sophie Rommel; Natalie C Momen; Nina Maren Molenaar; Esben Agerbo; Veerle Bergink; Trine Munk-Olsen; Xiaoqin Liu
Journal:  Acta Psychiatr Scand       Date:  2022-02-18       Impact factor: 7.734

4.  Perceived risk of neurodevelopmental outcomes in offspring related to psychotropic and mental illness exposures in pregnancy and breastfeeding: a cross-sectional survey of women with past or current mental illness.

Authors:  Ludvig D Bjørndal; Fatima Tauqeer; Kristin S Heiervang; Hanne K Clausen; Kristine Heitmann; Angela Lupattelli
Journal:  BMJ Open       Date:  2022-09-30       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.